Acadian Asset Management’s Aldeyra Therapeutics ALDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $735K | Buy |
192,402
+96,442
| +101% | +$368K | ﹤0.01% | 1054 |
|
|
2025
Q1 | $551K | Buy |
95,960
+94,681
| +7,403% | +$544K | ﹤0.01% | 1061 |
|
|
2024
Q4 | $6K | Sell |
1,279
-253,035
| -99% | -$1.19M | ﹤0.01% | 1568 |
|
|
2024
Q3 | $1.37M | Sell |
254,314
-191,572
| -43% | -$1.03M | ﹤0.01% | 853 |
|
|
2024
Q2 | $1.48M | Sell |
445,886
-6,563
| -1% | -$21.7K | ﹤0.01% | 869 |
|
|
2024
Q1 | $1.48M | Buy |
452,449
+233,169
| +106% | +$762K | 0.01% | 743 |
|
|
2023
Q4 | $768K | Buy |
+219,280
| New | +$768K | ﹤0.01% | 931 |
|
|
2021
Q1 | – | Sell |
-33,986
| Closed | -$233K | – | 2039 |
|
|
2020
Q4 | $233K | Buy |
+33,986
| New | +$233K | ﹤0.01% | 1496 |
|
|
2020
Q3 | – | Sell |
-159,445
| Closed | -$665K | – | 2152 |
|
|
2020
Q2 | $665K | Buy |
159,445
+126,347
| +382% | +$527K | ﹤0.01% | 1097 |
|
|
2020
Q1 | $82K | Buy |
33,098
+28,079
| +559% | +$69.6K | ﹤0.01% | 1390 |
|
|
2019
Q4 | $29K | Buy |
+5,019
| New | +$29K | ﹤0.01% | 1679 |
|
|
2019
Q2 | – | Sell |
-16,044
| Closed | -$145K | – | 1746 |
|
|
2019
Q1 | $145K | Buy |
+16,044
| New | +$145K | ﹤0.01% | 1430 |
|
|
2018
Q3 | – | Sell |
-13,833
| Closed | -$110K | – | 1650 |
|
|
2018
Q2 | $110K | Buy |
13,833
+5,915
| +75% | +$47K | ﹤0.01% | 1216 |
|
|
2018
Q1 | $59K | Buy |
7,918
+2,384
| +43% | +$17.8K | ﹤0.01% | 1331 |
|
|
2017
Q4 | $38K | Buy |
+5,534
| New | +$38K | ﹤0.01% | 1267 |
|